The U.S. drug discovery outsourcing market size is anticipated to reach USD 5.58 billion by 2033 and is expected to expand at a CAGR of 9.52% during the forecast period, according to a new report by Grand View Research, Inc. The combination of strategic, economic, and technological factors reshapes the pharmaceutical landscape. The increasing complexity of drug development has...